Measurement of glucose area under the curve using minimally invasive interstitial fluid extraction technology: evaluation of glucose monitoring concepts without blood sampling.

BACKGROUND Monitoring postprandial hyperglycemia is crucial in treating diabetes, although its dynamics make accurate monitoring difficult. We developed a new technology for monitoring postprandial hyperglycemia using interstitial fluid (ISF) extraction technology without blood sampling. The glucose area under the curve (AUC) using this system was measured as accumulated ISF glucose (IG) with simultaneous calibration with sodium ions. The objective of this study was to evaluate this technological concept in healthy individuals. METHODS Minimally invasive ISF extraction technology (MIET) comprises two steps: pretreatment with microneedles and ISF accumulation over a specific time by contact with a solvent. The correlation between glucose and sodium ion levels using MIET was evaluated in 12 subjects with stable blood glucose (BG) levels during fasting. BG and IG time courses were evaluated in three subjects to confirm their relationship while BG was fluctuating. Furthermore, the accuracy of glucose AUC measurements by MIET was evaluated several hours after a meal in 30 subjects. RESULTS A high correlation was observed between glucose and sodium ion levels when BG levels were stable (R=0.87), indicating that sodium ion is a good internal standard for calibration. The variation in IG and BG with MIET was similar, indicating that IG is an adequate substitute for BG. Finally, we showed a strong correlation (R=0.92) between IG-AUC and BG-AUC after a meal. CONCLUSIONS These findings validate the adequacy of glucose AUC measurements using MIET. Monitoring glucose using MIET without blood sampling may be beneficial to patients with diabetes.

[1]  Ryan F. Donnelly,et al.  Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety , 2010, Drug delivery.

[2]  Mark R Prausnitz,et al.  Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using microneedles. , 2005, Diabetes technology & therapeutics.

[3]  Pavel Zakharov,et al.  Cutaneous blood perfusion as a perturbing factor for noninvasive glucose monitoring. , 2010, Diabetes technology & therapeutics.

[4]  Bruce A Buckingham,et al.  Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study. , 2004, The Journal of pediatrics.

[5]  R. Sack,et al.  Tear Glucose Dynamics in Diabetes Mellitus , 2006, Current eye research.

[6]  Ryan F Donnelly,et al.  Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: assessments by transepidermal water loss. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[7]  R. Potts,et al.  Physiological differences between interstitial glucose and blood glucose measured in human subjects. , 2003, Diabetes care.

[8]  R. Potts,et al.  Glucose monitoring by reverse iontophoresis , 2002, Diabetes/metabolism research and reviews.

[9]  Stephen Colagiuri,et al.  Guideline for management of postmeal glucose. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[10]  R. Guy,et al.  Electroosmosis in transdermal iontophoresis: implications for noninvasive and calibration-free glucose monitoring. , 2004, Biophysical journal.

[11]  Andrea Tura,et al.  Noninvasive glycaemia monitoring: background, traditional findings, and novelties in the recent clinical trials , 2008, Current opinion in clinical nutrition and metabolic care.

[12]  Richard H Guy,et al.  Noninvasive and minimally invasive methods for transdermal glucose monitoring. , 2005, Diabetes technology & therapeutics.